Articles dans des revues avec comité de lecture (191)
  1. 61. Burny, W., Callegaro, A., Bechtold, V., Clément, F., Delhaye, S., Fissette, L., Janssens, M., Leroux-Roels, G., Marchant, A., van den Berg, R. R., Garçon, N., van der Most, R., Didierlaurent, A. M., Carletti, I., Esen, M., Gabor, J. J., Haelterman, E., Hervé, C., Horsmans, Y., Janssens, M., Kremsner, P. G. G. P., Moris, P., Schwarz, T. F., da Silva, F. T., Van Belle, P., Van Damme, P., & Zuchner, D. (2017). Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans. Frontiers in immunology, 8(AUG), 943. doi:10.3389/fimmu.2017.00943
  2. 62. Delforge, M.-L., Costa, E., Brancart, F., Goldman, D., Montesinos Hernandez, I., Zaytouni, S., Marchant, A., & donner, C. (2017). Presence of Cytomegalovirus in urine and blood of pregnant women with primary infection might be associated with fetal infection. Journal of clinical virology, 90, 14-17. doi:10.1016/j.jcv.2017.03.004
  3. 63. Marchant, A., Sadarangani, M., Garand, M., Dauby, N., Verhasselt, V., Pereira, L., Bjornson, G., Jones, C. E., Halperin, S. A., Edwards, K., Heath, P., Openshaw, P. P., Scheifele, D. D., & Kollmann, T. (2017). Maternal immunisation: collaborating with mother nature. Lancet. Infectious diseases, 17(7), e197-e208. doi:10.1016/S1473-3099(17)30229-3
  4. 64. Kollmann, T., Kampmann, B., Mazmanian, S. S., Marchant, A., & Levy, O. (2017). Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny. Immunity, 46(3), 350-363. doi:10.1016/j.immuni.2017.03.009
  5. 65. Abu-Raya, B., Kollmann, T., Marchant, A., & MacGillivray, D. D. (2016). The immune system of HIV-exposed uninfected infants. Frontiers in immunology, 7(SEP), 383. doi:10.3389/fimmu.2016.00383
  6. 66. Abu-Raya, B., Smolen, K., Willems, F., Kollmann, T., & Marchant, A. (2016). Transfer of maternal antimicrobial immunity to HIV-exposed uninfected newborns. Frontiers in immunology, 7(AUG), 338. doi:10.3389/fimmu.2016.00338
  7. 67. Ruck, C. C., Reikie, B. B., Marchant, A., Kollmann, T., & Kakkar, F. (2016). Linking susceptibility to infectious diseases to immune system abnormalities among HIV-exposed uninfected infants. Frontiers in immunology, 7(AUG), 310. doi:10.3389/fimmu.2016.00310
  8. 68. Kollmann, T., & Marchant, A. (2016). Towards Predicting Protective Vaccine Responses in the Very Young. Trends in immunology, 37(8), 523-534. doi:10.1016/j.it.2016.05.005
  9. 69. Leroux-Roels, G., Clément, F., Gabor, J. J., Esen, M., Hens, A., Carletti, I., Fissette, L., Tavares Da Silva, F., Burny, W., Janssens, M., Moris, P., Marchant, A., Didierlaurent, A. M., Van Der Most, R., Garçon, N., Van Belle, P., Van Mechelen, M., Levy, J., Van Damme, P., Schwarz, T. F., Horsmans, Y., Jilg, W., Kremsner, P. G. G. P., & Haelterman, E. (2016). Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial. Clinical immunology, 169, 16-27. doi:10.1016/j.clim.2016.05.007
  10. 70. Bayard, C., Boddaert, J., Bajolle, F., Appay, V., Sauce, D., Lepetitcorps, H., Roux, A., Larsen, M. R., Fastenackels, S., Salle, V., Vieillard, V., Marchant, A., & Stern, M. (2016). Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans. European Journal of Immunology, 46(5), 1168-1179. doi:10.1002/eji.201546179
  11. 71. Dauby, N., Sartori, D., Kummert, C., Lecomte, S., Haelterman, E., Delforge, M.-L., donner, C., Mach, M., & Marchant, A. (2016). Limited Effector Memory B-Cell Response to Envelope Glycoprotein B during Primary Human Cytomegalovirus Infection. The Journal of infectious diseases, 213(10), 1642-1650. doi:10.1093/infdis/jiv769
  12. 72. Adler, C., Haelterman, E., Barlow, P., Marchant, A., Levy, J., & Goetghebuer, T. (2015). Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country. PloS one, 10, 8. doi:10.1371/journal.pone.0135375
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>